Carlos H Barcenas

Carlos H. Barcenas is an Associate Professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center. His research focuses on optimizing breast cancer treatment, particularly personalizing therapies for hormone receptor-positive/HER2-negative metastatic disease, and evaluating the impact of GLP-1 receptor agonists on weight loss and clinical outcomes in breast cancer survivors. His recent publications examine cardiomyopathy risk in patients with cancer and diabetes, HER2-low status prevalence, and chemotherapy declination in early-stage disease. He has also contributed to guidance on lymph node management in the era of therapy de-escalation. His work integrates surgical oncology, radiation oncology, and pharmacology to advance cancer care and treatment strategies.